At present, the most commonly used classical biomarkers for the diagnosis of HCC are alpha fetoprotein (AFP), AFP-L3 and prothrombin induced by vitamin K absence-II (PIVKA-II) (Wang X et al., 2022). This evidence concerns the gene AFP and hepatocellular carcinoma.